Peripheral blood cytopenias are common in patients receiving intensive care, particularly in those with multiple organ failure. To assess the contribution of bone marrow hypoplasia in such patients 44 bone marrow samples from 24 patients under intensive care were studied by standard morphological techniques and by the granulocyte-macrophage colony forming cell (GM-CFC) assay. Frequently observed morphological abnormalities in the bone marrow included the following: (i) a reduction in overall cellularity in seven patients, with a progressive decrease in most patients studied sequentially; (ii) an increase in the number of actively phagocytic macrophages; and (iii) a disruption of normal bone marrow architecture with the accumulation of intercellular hyaluronic acid glycosaminoglycan. Mean GM-CFC growth was significantly reduced when compared with that in a group of normal controls.
pared with that in a group of normal controls.
In four of five patients studied sequentially GM-CFC growth became subnormal in association with a reduction in bone marrow cellularity. Inhibitory serum factors were not identified. These morphological abnormalities are similar to the changes observed in gelatinous degeneration of the bone marrow.
In both situations disruption of the haemopoietic microenvironment, with the accumulation of hyaluronic acid proteoglycan, may be an important factor in the inhibition of haemopoietic progenitor cell growth. The elements may be involved in the development of anaemia, including blood loss, the "anaemia of chronic disorder,"2 3 and haemolysis. 4 The presence of thrombocytopenia and neutropenia is often explained on the basis of an increase in the peripheral consumption of mature cells due, for example, to infection or disseminated intravascular coagulation. From previous observations, however, it is our impression that bone marrow hypoplasia and the subsequent failure of blood cell production is an important additional factor in the development of these cytopenias.
Of particular interest is the possible association between multiple organ failure and impaired haemopoiesis. The syndrome of sequential/progressive multiple organ failure came to who had received cytotoxic chemotherapy or radiotherapy were excluded. Eighteen patients were admitted within 24 hours of surgery and anaesthesia with nitrous oxide. None of the patients was exposed to nitrous oxide after admission to the Unit during the period of study. All patients received parenteral folate supplementation during admission (1 mg/ day). They remained in the ICU for a mean of 20 days (range seven to 49 days). The study was approved by the local ethical committee. Whenever possible, informed consent for participation in the study was obtained from the patients; otherwise it was obtained from their next of kin.
BONE MARROW MORPHOLOGY
Forty four bone marrow samples were obtained from the 24 patients in the study; 28 samples from 11 patients included a bone marrow trephine biopsy specimen. Eleven patients were studied on only one occasion, on average nine days after admission (range one to 30 days); 13 patients were studied sequentially, on two or more occasions, every three days for periods of up to 14 days.
All samples were processed using standard techniques. Aspirate smears were fixed in methanol and stained by May-GruniwaldGiemsa and Perls's reaction for iron. Trephine biopsy specimens were decalcified, Myeloid progenitor cells were assayed in the granulocyte-macrophage colony forming cell assay (GM-CFC).'9 Briefly, bone marrow cells were collected into 10 ml Hanks's balan- Megaloblastic erythropoiesis was observed during the first week of admission in seven patients (cases 1, 2, 4-6, 11, and 13), six of whom had been admitted following anaesthesia with nitrous oxide. In the six patients in whom follow up studies were available erythropoiesis became normoblastic in four (cases 2, 4, 5, and 11) and in these, the original megaloblastic change is likely to have been related to the inactivation of vitamin B12 by nitrous oxide. 2' In two patients, however (cases 1 and 6), megaloblastic change persisted for periods of up to 18 days and, in addition, a further three patients were identified (cases 9, 16, and 24) in whom megaloblastic change developed seven to 20 days after admission. These five patients with unexplained megaloblastic change all had normal pre-treatment serum vitamin B,2, serum and red cell folate concentrations, and they had all received prophylactic folate supplements.
Abnormal cells A moderate increase in the number of mature plasma cells (up to 10%) was noted in 13 (54%)
patients. An almost universal observation in 22 (9200) patients was a variable and sometimes striking increase in the number of foamy, actively phagocytic macrophages. Many of the macrophages contained phagocytosed red cells, granulocytes or platelets. They occurred singly or in clumps and in the latter case were sometimes associated with fibrillary, pinkstaining material. There was a progressive increase in the number of macrophages in 11 of the 13 (85O ) patients studied sequentially.
Stromal changes Stromal changes were most clearly appreciated in the 11 patients in whom trephine biopsy specimens were obtained. Typically, there was a localised disruption of normal bone marrow architecture, usually associated with the accumulation of intercellular ground substance together with varying degrees of fat atrophy and loss ofhaemopoietic cells. In some patients bone marrow necrosis (one out of 11) and focal, fibrinous exudates (six out of 11) were also identified. A mild, diffuse increase in reticulin was noted in five of 11 patients.
A focal increase in pink-staining ground substance was seen in 10 of 11 patients and there was a progressive increase in the seven patients with follow up trephine biopsies. The material was associated with varying degrees of fat atrophy and loss of haemopoietic cells. In marrow aspirates it was identified in 13 (540%) patients as pink-staining, fibrillary material associated with bone marrow fragments or clumps of macrophages. The material stained weakly with PAS; pre-digestion with diastase had no effect. It also stained with alcian blue, much more strongly at pH 2 5 than at pH 1 -0; staining was prevented by pretreatment with 5) . The difference between the two groups was significant (p < 0-01). In six (38%) patients colony growth was less than the range found in normal subjects.
In five patients GM-CFC assays were performed on more than one occasion. In four of five patients GM-CFC growth decreased and became subnormal during admission to the ICU; in each case this was associated morphologically with a reduction in bone marrow cellularity (fig 6) . All four patients died.
The addition ofautologous serum to cultures of patients' bone marrow produced no inhibition of colony growth, and similarly, the addition of patients' serum to cultures of bone marrow from normal subjects did not inhibit colony growth. There was therefore no evidence of any serum factors inhibitory to haemopoietic progenitor cell growth.
Discussion
We have described a constellation of morphological abnormalities in the bone marrow of a group of patients with critical illness. In essence they consist of: (1) hypoplasia, which was also reflected by a reduction in haemopoietic progenitor cell growth in vitro; (2) 
